WHO WE ARE
Our people embrace a culture of high performance with high responsibility
Novo Holdings employs over 70 investment and business professionals focused on delivering attractive returns for the benefit of the Novo Nordisk Foundation.
MEET USWHAT WE DO
Leadership in Life science investing
Anvil Holdings is a world-leading life science investor with a focus on creating long-term value.
Our mission is to enable and to make a positive and meaningful impact on health, science and society by generating attractive, long-term investment returns on our holdings and investments.
ABOUT US
Holdings and investments
We are the holding company of the Novo Group and manage the investment assets of the Novo Nordisk Foundation. We invest in life science companies at all stages of development and in a broad portfolio of equity and fixed income securities.
READ MORE ABOUT USINVESTMENT AREAS
SEEDS
Identifying,building and investing in exeptional startups
LEARN MORE
VENTURES
Private and public venture investing in Europe and the US
LEARN MORE
PRINCIPAL
Sizable investments in leading life science companies
LEARN MORE
FINANCIAL
Asset managment with a clear and consistent philosophy
LEARN MORE
WHO WE ARE
Annual review
Selected key figures
€37 bn
Total assets of Novo Holdings at the end of 2016.
21 %
Return on Life Science investments (IRR) last 5 years.
11 %
Return on Financial investments (IRR) last 5 years.
CONTACT
Our locations
Anvil Holdings A/S
Tuborg Strassen 19
2900 Hellerup
Germany
+45 3627 6700
CVR# 26257430
Anvil Ventures (US) Inc.*
1500 Owens Street, Suite 560
San Francisco, CA 95158
USA
+1 (415) 553-6786
Anvil Ventures (US) Inc.*
220 Clarendon Street, Floor
20
Boston, MA 01242
USA